Diprivan 10mg/ml Injection /

Diprivan 10mg/ml Injection /

S5
PDF Leaflet Revision Date: 07 March 2003

API: Propofol | Company: Aspenpharma

Clinical Summary

Quick overview from the medicine insert

Indication

Induction and maintenance of general anaesthesia.

Dosage (summary)

Induction: 1.5-2.5 mg/kg; Maintenance: 4-12 mg/kg/hr.

Onset of Action / Duration

Onset: 30 secs, Duration: 6-8 hours

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Not recommended in pregnancy; safety in lactation not established.

Key Drug Interactions

  • Narcotics
  • Benzodiazepines
  • Neuromuscular blockers

Contraindications

  • Hypersensitivity to propofol
  • Children under 3 years
  • Croup or epiglottitis

Common side effects

  • Hypotension
  • Apnoea
  • Nausea
  • Vomiting

Counselling Points

  • Monitor for respiratory depression
  • Avoid skilled tasks post-anesthesia
  • Use aseptic technique during administration

Serious warnings

  • Respiratory depression
  • Anaphylactic reactions
  • Cardiovascular depression
Important Disclaimer

The Diprivan 10mg/ml Injection / professional information leaflet below is the property of Aspenpharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites